Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BH4 and Antioxidants for Endothelial Function in Cystic Fibrosis
NCT01772758Phase 2Completed
- Sponsor
- Augusta University
- Start
- Aug 2011
- Primary completion
- Jun 2016
- Modality
- Allosteric Modulators, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of sapropterin in cystic fibrosis (CF), sponsored by Augusta University. Started Aug 2011; status: completed.
02
Drugs
sapropterin
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT01772758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01772758.